ABSTRACT
Purpose: Kidney stone disease affects 5% of the population and is associated with non-negligible morbidity. Retrograde intrarenal surgery and percutaneous nephrolithotomy are the treatments of choice. We analyzed the results from our patients who underwent retrograde intrarenal surgery at controlled pressure. Materials and Methods: We conducted an observational, descriptive, retrospective study of 403 patients who underwent retrograde intrarenal surgery at the Hospital Clínico Universitario Lozano Blesa (Zaragoza, Spain) between January 2013 and December 2019. Results: The mean surgical time was 111.1 minutes, with a mean stone volume of 3.5 cm3 (maximum volume, 38.3 cm3). A total of 70 patients (17.3%) developed postoperative Clavien-Dindo complications64 minor (91.4%) and 6 major (8.6%). In addition, 28 patients (6.9%) presented with an early complication (<3 months), with urinary tract infection and pyelonephritis being the most common. The stone-free rate was 69.0%, with a retreatment rate of 4.7%. Conclusions: Sex was statistically significantly related to the onset of minor Clavien postoperative complications (p = 0.001). Similarly, corticosteroid use was associated with the onset of major Clavien complications (p = 0.030). Neither surgical time nor stone volume was found to be statistically significantly related to the onset of Clavien postoperative complications or early complications (AU)
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Operative Time , Kidney Calculi/surgery , Surgical Procedures, Operative/adverse effects , Surgical Procedures, Operative/methods , Retrospective Studies , Postoperative ComplicationsSubject(s)
Urinary Bladder Neoplasms , Female , Humans , Male , Urinary Bladder , Urinary Bladder Neoplasms/diagnostic imagingSubject(s)
Humans , Male , Aged, 80 and over , Urinary Bladder Neoplasms/diagnosis , Palliative CareABSTRACT
No disponible
Subject(s)
Humans , Male , Aged, 80 and over , Antineoplastic Agents/administration & dosage , Carcinoma, Basal Cell/drug therapy , Imiquimod/administration & dosage , Skin Neoplasms/drug therapy , Administration, TopicalSubject(s)
Penile Diseases , Penile Induration , Humans , Male , Necrosis , Penile Diseases/surgery , Penile Erection , Penis , SkinABSTRACT
No disponible
Subject(s)
Humans , Male , Middle Aged , Penile Diseases/surgery , Penile Diseases/pathology , NecrosisABSTRACT
72 year old female with a historyof breast cancer in remission, under study formonosymptomatic haematuria. Cystoscopy studyshows pigmented mucosal areas...
Paciente mujer de 72 años con antecedentede cáncer de mama en remisión, enestudio en urología por hematuria macroscópicamonosintomática. Se realiza cistoscopia observandoáreas de mucosa pigmentada...
Subject(s)
Urinary Bladder Neoplasms , Aged , Cystoscopy , Female , Hematuria , Humans , Urinary Bladder Neoplasms/diagnosisABSTRACT
No disponible
Subject(s)
Humans , Female , Aged , Urinary Bladder Neoplasms/diagnosis , Incidental Findings , Cystoscopy , Hematuria , Tomography, Emission-ComputedABSTRACT
No disponible
Subject(s)
Humans , Male , Middle Aged , Urinary Sphincter, Artificial/adverse effects , Urologic Surgical Procedures, Male/methods , Prosthesis FailureSubject(s)
Urinary Sphincter, Artificial/adverse effects , Humans , Male , Middle Aged , Prosthesis FailureABSTRACT
No disponible
Subject(s)
Humans , Male , Middle Aged , Penile Neoplasms/diagnostic imaging , Dysuria/etiology , Carcinoma, Verrucous/diagnostic imaging , Papillomaviridae/pathogenicityABSTRACT
No disponible
Subject(s)
Humans , Male , Adult , Varicocele/therapy , Embolization, Therapeutic , Low Back Pain/etiologySubject(s)
Back Pain/etiology , Embolization, Therapeutic/adverse effects , Varicocele/therapy , Adult , Humans , MaleABSTRACT
No disponible
Subject(s)
Humans , Male , Aged , Weight Gain/physiology , Magnetic Resonance Spectroscopy/methods , Cysts/pathology , Kidney Pelvis/metabolism , Urinary Retention/metabolism , Urinary Retention/pathology , Weight Gain/genetics , Magnetic Resonance Spectroscopy/standards , Cysts/complications , Kidney Pelvis/pathology , Urinary Retention/complications , Urinary Retention/diagnosisSubject(s)
Cysts/complications , Urinary Bladder Diseases/complications , Urinary Retention/etiology , Abdomen , Aged , Chronic Disease , Humans , MaleABSTRACT
No disponible
Subject(s)
Humans , Male , Adult , Cysts/metabolism , Cysts/pathology , Imaging, Three-Dimensional/methods , Urinary Tract Infections/metabolism , Urinary Tract Infections/urine , Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/metabolism , Pelvic Infection/pathology , Cysts/rehabilitation , Cysts/surgery , Imaging, Three-Dimensional/instrumentation , Urinary Tract Infections/complications , Urinary Tract Infections/diagnosis , Prostatic Neoplasms/complications , Prostatic Neoplasms/genetics , Pelvic Infection/metabolismABSTRACT
OBJECTIVES: To study the efficacy and safety of the Perigee® System for the treatment of anterior vaginal prolapse in our experience with a medium term follow-up. METHODS: Prospective analysis on 48 consecutive patients with stage II-IV cystocele diagnosed from June 2006 until June 2009 using the Pelvic Organ Prolapse Quantitation classification without other associated prolapses. All diagnoses were done by a single urological specialist and follow-up is between 3 to 6 years. The questionnaire Patient Global Impression of Improvement was carried out before surgery, at the first follow up checking at one month, and at 6 and 12 months. The variables evaluated were age, presence of obesity, parity, prior hysterectomy, ASA class and stage of prolapse. RESULTS: The result, evaluating the questionnaire Patient Global Impression of Improvement, was cured or improved in 40 (83.3%) patients and 87.5% according to the Pelvic Organ Prolapse Quantitation, with a recurrence rate of 6.25%. Intraoperative complications were observed in 12.5% of the patients, postoperative in 4.2% and 41.5% after hospital discharge, pain being the most common complication (16.6%). The key variables for procedural failure were age 65 years >, obesity, parity ≥ 2, prolapse stage ≥ III and prior hysterectomy (p <0.05). CONCLUSIONS: In our series the Perigee® System allows anatomic repair with less morbidity, hospital stay and recovery time.